Repligen Corporation (RGEN)

Repligen Market Cap

Repligen has a market cap or net worth of $7.19 billion as of May 14, 2025. Its market cap has decreased by -22.57% in one year.

• Market Cap: 7.19B
• Enterprise Value: 7.18B
• 1-Year Change: -22.57%
• Ranking: #1034
• Category: Mid-Cap
• Stock Price: $128.04

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $7.19B, an increase of 25,500.30%. That is a compound annual growth rate of 23.31%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	7.39B	-8.35%
Dec 31, 2024	8.06B	-19.67%
Dec 29, 2023	10.04B	6.78%
Dec 30, 2022	9.40B	-35.80%
Dec 31, 2021	14.64B	45.21%
Dec 31, 2020	10.08B	109.40%
Dec 31, 2019	4.82B	108.18%
Dec 31, 2018	2.31B	46.35%
Dec 29, 2017	1.58B	51.58%
Dec 30, 2016	1.04B	11.88%
Dec 31, 2015	932.00M	43.85%
Dec 31, 2014	647.90M	48.87%
Dec 31, 2013	435.20M	122.72%
Dec 31, 2012	195.40M	83.30%
Dec 30, 2011	106.60M	-26.18%
Dec 31, 2010	144.40M	14.24%
Dec 31, 2009	126.40M	7.21%
Dec 31, 2008	117.90M	-41.78%
Dec 31, 2007	202.50M	137.12%
Dec 29, 2006	85.40M	-29.07%
Dec 30, 2005	120.40M	39.03%
Dec 31, 2004	86.60M	-33.64%
Dec 31, 2003	130.50M	57.04%
Dec 31, 2002	83.10M	28.04%
Dec 31, 2001	64.90M	-27.65%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	651.48B
Johnson & Johnson	353.38B
AbbVie	318.46B
Novo Nordisk	291.59B
UnitedHealth Group	284.13B
Abbott Laboratories	224.75B
Novartis AG	209.81B
AstraZeneca	209.59B